metformin has been researched along with Connective Tissue Diseases in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
Excerpt | Relevance | Reference |
---|
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vondra, K | 1 |
Hampl, R | 1 |
Nĕmcová, D | 1 |
Hill, M | 1 |
Hoza, J | 1 |
Kot'átková, A | 1 |
Stárka, L | 1 |
Vrbíková, J | 1 |
Zamrazil, V | 1 |
1 other study available for metformin and Connective Tissue Diseases
Article | Year |
---|---|
[Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
Topics: Adolescent; Adult; Androgens; Connective Tissue Diseases; Female; Glucocorticoids; Glucose; Growth H | 2002 |